Haploidentical/Mismatched Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for T Cell Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 5, 2012, Pages 716-721

  Wang, Yu ^a   Liu, Dai Hong ^a   Xu, Lan Ping ^a   Liu, Kai Yan ^a   Chen, Huan ^a   Chen, Yu Hong ^a   Han, Wei ^a   Zhang, Xiao hui ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Allogeneic; Haploidentical; Hematopoietic stem cell transplantation; HLA; Mismatched; T cell acute lymphoblastic leukemia

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE; SEMUSTINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; FOLLOW UP; HAPLOIDENTICAL MISMATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION PREVENTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; PRESCHOOL CHILD; SCHOOL CHILD; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; T CELL DEPLETION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING;

EID: 84859835016     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.08.024     Document Type: Article

References (16)

1. Marks D.I., Paietta E.M., Moorman A.V., et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood 2009, 14:5136-5145.
2. Huang X.J., Liu D.H., Liu K.Y., et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006, 38:291-297.
3. Xiao-Jun H., Lan-Ping X., Kai-Yan L., et al. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med 2008, 40:444-455.
4. Chen Y.H., Liu K.Y., Xu L.P., et al. Haplo-identical/mismatched hematopoietic stem cell transplantation without in vitro T-cell depletion for myelodysplastic syndrome. Bone Marrow Transplant 2010, 45:1333-1339.
5. Swerdlow S.H., Campo E., Harris N.L., et al. T lymphoblastic leukemia/lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 176-178. IARC Press, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
6. Moorman A.V., Harrison C.J., Buck G.A.N., et al. Karyotype is an independent prognostic factor in acute lymphoblastic leukaemia: analysis of cytogenetic data from patients treated on the MRC UKALL XII/ECOG 2993 trial. Blood 2007, 109:3189-3197.
7. Martin P., Nash R., Sanders J., et al. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998, 92:2303-2314.
8. Sullivan K.M. Graft-versus-host-disease. Hematopoietic Cell Transplantation 1999, 515-536. Blackwell Science, Boston, MA. 2nd ed. E.D. Thomas, K.G. Blume, S.J. Forman (Eds.).
9. Huang X.J., Liu D.H., Liu K.Y., et al. Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia. J Clin Immunol 2008, 28:276-283.
10. Huang X.J., Liu D.H., Liu K.Y., et al. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007, 92:414-417.
11. Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
12. Rowe J.M., Buck G., Burnett A.K., et al. Induction therapy for adults with acute lymphoblastic leukaemia: results of more than 1500 patients from the international ALL trial MRC UKALL XII/ECOG 2993. Blood 2005, 106:3760-3767.
13. Vitale A., Guarini A., Ariola C., et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood 2006, 107:473-479.
14. Fielding A.K., Richards S.M., Chopra R., et al. Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL): an MRC UKALL XII/ECOG 2993 study. Blood 2007, 109:944-950.
15. Thomas X., Boiron J.M., Huguet F., et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004, 22:4075-4086.
16. Annino L., Vegna M.L., Camera A., et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002, 99:863-871.